Biogen is Still in Limbo

·

·

Biogen is Still in Limbo

Biogen is unlikely to launch anything except for Nusinersen until 2018 or later, according to Bloomberg Intelligence, and most of what's on deck is
See Original Article

Obamacare Will Survive (With Some Tweaks)

Next Tuesday will be the start of open enrollment for Obamacare's state exchanges, which offer health insurance to the 7 percent of Americans who
See Original Article

Trump Executives Tout Brand Resilience at D.C. Hotel Opening

Executives used Wednesday's official opening of the Trump International Hotel Washington, D.C., to tout interest in the property during its initial weeks
See Original Article

Latest Analyst Ratings For Diplomat Pharmacy, Inc. (NYSE:DPLO)

Recently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Diplomat Pharmacy, Inc. (NYSE:DPLO).
See Original Article

From Bootstrapping To IPO, BlackLine Shows The Way

BlackLine offers a cloud-based software platform that supports critical accounting processes such as the financial close, account reconciliation,
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.